Viewing Study NCT05991206


Ignite Creation Date: 2025-12-26 @ 4:01 PM
Ignite Modification Date: 2025-12-29 @ 4:54 AM
Study NCT ID: NCT05991206
Status: RECRUITING
Last Update Posted: 2023-12-27
First Post: 2023-08-06
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Real-World Study of Atezolizumab in Combination With Platinum-Based Doublet Chemotherapy as Neoadjuvant Therapy for Resectable Stage II-IIIB NSCLC
Sponsor: Hunan Province Tumor Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Outcomes Module Eligibility Module Contacts Locations Module